Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke Dear editor, Appropriate intravenous thrombolysis with tissue plasminogen activator (t-PA) is an effective treatment for acute ischaemic stroke (AIS). 1 The recommended dose is 0.9 mg/kg, with a maximum of 90 mg for patients weighing above 100 kg. 1 Under or over dosing is associated with worse outcomes. [2] [3] [4] [5] [6] Inaccuracies in estimation of patient weight are reported to occur in 12-37% of thrombolysis cases. [3] [4] [5] This may be attributable to the inability of stroke patients to communicate their weight and challenges in quickly weighing patients given the urgency of the thrombolysis setting. 4 For this reason, it is common for patients' estimated weight to be used when dosing t-PA in AIS.
We retrospectively compared the estimated weight to that later measured in all patients thrombolysed at Imperial College Healthcare NHS Trust from October 2012 to June 2015 inclusive. Paired weights were obtained for a total of 342 patients.
Both estimated and measured weights followed an approximate normal distribution with mean and standard deviation 71 kg and 14 kg, and 72 kg and 16 kg, respectively. The differences between the estimated and measured recordings for each patient also approximated a normal distribution, with a two-tailed paired t-test highlighting the two sets of readings as statistically distinct (p ¼ 0.02). Inaccuracies in weight estimation resulted in over and under dosing of t-PA to a magnitude of greater than 5 mg for 25% of patients and greater than 9 mg for 10% of patients. For measured weights above 72 kg, the estimated weight tended to be too low, whereas for measured weights below 72 kg the estimated weight tended to be too high.
The results further highlight inaccuracy in estimation of patient weight resulting in consequent impact on dosing of t-PA for thrombolysis in AIS. Appropriate measures must be made to reliably ascertain patient weight wherever possible.
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